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Erythropoietin (EPO) stimulates proliferation and differentiation of late crythroid precursor cells (CFU-E) and thereby determines the rate of 
crythropoiesis, Liver is the major erythropoietic site in a fetus. We dealt with developmental changes in CFU-E and EPO rcccptor (EPO-R) of 
fetal mouse liver. The affinity of the EPO-R to EPO was unchanged uring fetal development. The popupation size of CFU-E, the number of EPO-R 
per liver cell, and EPO-R mRNA decreased as gestation proeceded, in a pattern indicating that the expression of EPO-R on erythroid precursor 
cells in fetal mouse liver is governed mostly by the process of mRNA production. 
Erythropoietin receptor; Fetal liver; Erythropoietin receptor mRNA; Developmental change 
1. INTRODUCTION 
During the development of fetal mice with their gesta- 
tion period of 21 days, erythropoiesis first detectable 
at day 7 or 8 in the yolk sac [I]. The erythropoietic site 
shifts from the yolk sac to the fetal liver, which becomes 
the main erythropoietic organ during gestation; ery- 
thropoiesis in the iiver starts on day 10.5 [2]. Spleen and 
bone marrow are responsible for murine erythropoiesis 
after birth but erythropoiesis in these organs is not de- 
tected until day I5 of gestation 131. Erythropoietin 
(EPO) is a glycoprotein that is the major physiological 
regulator of erythropoiesis; EPO supports survival of 
the late erythroid precursor cells and enhances their 
proliferation and differentiation through binding to its 
specific receptor [4]. The CFU-E, late eythroid pre- 
cursor cells, are the main targets of EPO [4]. 
Investigation of the binding characteristics of EPO 
receptor (EPO-R) on the erythroid cells of hamster yolk 
sac has indicated that the number of EPO-R per cell and 
the affinity of EPO-R to EPO change during hamster 
ontogeny [S]. Interestingly, the binding affinity de- 
creased as gestation proceeds; the affhity on day 13 is 
one-thirtieth that on day 8 [S]. The binding properties 
of EPO-R and the products of cross-linking between 
EPO and EPO-R have been studied in fetal mouse livei 
cells at a certain stage of gestation [6--S] but the devel- 
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opmental changes in the properties of EPO-R have not 
been reported. Here we report on the binding charac- 
teristics of EPO-R, the expression of EPO-R mRNA, 
and the number of CFU-E in fetal liver cells during 
mouse ontogeny. 
. 2. MATERIALS AND METHODS 
Recombinant human EPO (rHuEP0) was produced in baby 
hamster kidney cells [9] and isolated [IO] as described previously. 
Radioiodination of rHuEP0 (about 30 ~Ci&g EM)) was done as 
reported clscwhcre [6]. Mice (ICR. unless otherwise indicated) were 
purchased from Shimizu Laboratory Supplies (Kyoto, Japan). For 
preparation ofreticulocytcs. male mice (8 weeks old) rcceivcd 5intn- 
peritoneal injections of 50 mg&g phenylhydrazine solution (5 mdml 
in PBS) on 5 consecutive days, On day 2 after the last injection, blood 
was withdrawn and the cell preparation enriched rcticulocytcs (>90%) 
was used to isolate RNA. For preparation of spleen cnrichcd EPO- 
responsive cells [I I], mice were made anemic by injections of phcnyl- 
hydrazine as described elsewhere [12]. For the same purpose, C3H 
mice received injections of tnnsplantablc erythroblastis cells [13] as 
reported previously [14]. Spleens from these mice were us-cd to isolate 
RNA. 
2.2. Cell culture 
Cells were cultured in a humid 5% CQ atmosphere at 37°C. All 
media for cell culture contained 100 If/ml penicillin and 100 pdml 
streptomycin. Friend crythrolcukemia cells, TSA8 [Is], and mouse 
myelomonocytic leukemia cells, Ml [16]. were maintained in IMDM 
(G&o-BRL Life Technologies Inc., Tokyo) supplemented with 10% 
fetal calf serum (Wittaker Bioproducts Inc.. MD) and in RPM1 1646 
(Gibco-BRL Life Technologies Inc., Tokyo) supplemented with 10% 
horse serum (Wittaker Bioproducts Inc., MD), respcctivcly. 
2.3. Bitt&~ of EPU u&it f&u1 mouse fiiwr cefk 
Binding of [‘zJfjrHuEPO with ictal InouX liver cells was done as 
described previously 161, A singlc-cctl suspension (4% 10bcclls)of livers 
obtained from fetuses at dilTcrent staps of gestation was incubated 
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with [‘~51]rHuEP0 for 3 h at 15’C in the presence or absence of a 
2OOJold excess of unlabeled rHuEP0. Binding was assayed at 10 
concentrations of [rz51]rHuEP0, ranging from 0.02 to 4.8 nM. Binding 
mixtures contained 0.1% NaN,, an inhibitor of the receptor-mediated 
internalization of the ligand. Specific binding was calculated by sub- 
traction of the nonspecific binding (binding in the presence ol: un- 
labeled EPO) from total binding (binding in the absence of unlabeled 
EPO). Data on specific binding were analyzed by the method of 
Scatchard [ 171 to estimate the number of binding sites and the dissocia- 
tion constants of ligand-receptor complexes. One Scatchard plot was 
made with liver cells of fetuses from one pregnant mouse (-10 feluses/ 
mouse). Three plots of each gestation time were made to estimate the 
binding parameters. 
2.4. RNA prcparatfon and bfot rmafyses 
Total RNA was prepared by the guanidinium thiocyanatc-CsCI 
method [l8]. Northern blot analysis was done by the method of 
Thomas [l9]. Details of analyses by Northern blotting and slot blot- 
ting were as described in a previous paper [20]. The probe for blot 
analyses of EP0.R mRNA was prepared by isolation of a I .7 kb Kprl 
fragment from a plasmid (the kind gift of Dr. D’Andrea) that con- 
tained cDNA of mouse EPO-R [21], and the probe was labeled with 
3zP by multipriming of the fragment. 
The CFU-E in the fetal ivers were assayed by the method of Iscovc 
et al. [22]. The cells (2 x IO’ to 2 x IO” cells) from fetal ivers at different 
stages of gestation were cultured in methylcellulose for 2 days in the 
presence of 2 U/ml rHuEP0. Erythroidcolonies that were stained with 
benzidine and that consisted of 8 or more cells were counted. Tripli- 
cate mcthylcellulose cultures of fetal liver cells from two pregnant mice 
at each gestation time were done. 
3. RESULTS AND DISCUSSlON 
Scatchard analyses of El?0 binding to EPO-R on a 
variety of erythroid precursor cells including cell lines 
have shown that certain cells express ingle-affinity re- 
ceptors but other cells express high- (& = -100 PM) and 
Pig. 
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I. Scatchard plot of EPO binding to liver cells of a fetal mouse 
on day 13 of gestation. 
Table I 
Perccntuge of CFU-E in mouse l’elal iver and binding parameters of 
EPO to mouse fetal liver cells 
Day ofgestation K, (PM) Receptors/liver CFU-E (% in 
cell liver cells) 
12 
I3 
14 
15 
16 
19 
106-L 8 376 2 I4 - 
Illf 9 419 & IS 5.86 4 0.20 
114f 9 335 + I4 
137+ II 241 f I2 
94? 6 l26? 8 I.01 ?: 0.16 
loo?: 9 40& 5 0.32 2 0.06 
- = not determined. Values are means dz SD. 
low- (& = -500 PM) affinity receptors (reviewed in [23]) 
and the mechanism of the presence of binding sites with 
different affinities is not known. Were we assayed bind- 
ing to fetal mouse liver cells in a wide range of EPO 
concentrations (0.02-4.8 nM) so that both low- and 
high-affinity receptors could be detected. Fig. 1 shows 
a representative Scatchard plot. There was a deviation 
from linearity at high concentrations of the ligand, 
suggesting the presence of low-affinity sites. The devia- 
tion, however, was not always reproducible and it was 
difficult to estimate binding parameters of low-affinity 
sites. The occupancy of high-affinity sites by EPO in- 
duces the growth and differentiation of CFU-E [4], so 
we deal here only with high-affinity binding sites. The 
affinity of fetal mouse liver cells to El?0 was unchanged 
in various stages of gestation, but the number of binding 
kb 
9.5 - 
7.5 - 
4.4 - 
2.4 - 
1.4 - 
0.3 - 
1234567 
Fig. 2. Northern blot analysis of EPO-R mRNA. Poly(A)-selected 
RNA (!O pg) WLS used. (Lane 1) Fetal mouse liver on day I3 of 
gestation; (lane 2) TSAR, mouse erythrolcukemic cell line; (lane 3) 
spleen of an anemic adult mouse; (lane 4) ELM, transplantable mouse 
erythroleukemic cell line; (lane 5) adult mouse liver; (lane 6) MI, 
mouse niyelomonocytic cell line; (lane 7) mouse reticulocytes. 
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Fig. 3. Slot-blot analysis of EW-R mRNA of fetal mouse liver. (a) Hybridization with a “‘P-labeled probe for EPO-R mRNA. (b) Hybridization 
with a ‘“P-labeled probe for actin mRNA. (c) Intensity of the bands. Intensity was measured with a densitometer with 10,ug of RNAand the value 
for a fetus on day I3 was defined as I .O. 
sites per liver cell between days 13 and 19 of gestation 
decreased as the gestation advanced (Table 1). 
CFU-E in fetal mouse ;iver were assayed by their 
ability to form erythroid colonies in vitro in the pres- 
ence of EPO. The calculated population size of CFU-E 
at days 13, 16, and 19 of gestation is shown in Table I; 
the proportion of CFU-E declined from 5.86% on day 
13 of gestation to 0.32% on day 19. This decline was 
roughly proportional to that of the number of EPO 
binding sites per liver cell. CFU-E are erythroid pre- 
cursor cells that express EPO-R at the highest number 
[18], and therefore the developmental change in the 
number of EPO-R per liver cell could arise from the 
change in the percentage of CFU-E. 
To identify a major step to control expression of 
EPO-R on the cell surface, we studied EPO-R mRNA 
in fetal livers of mice at different stages of gestation. 
EPO-R mRNA with a size of 2.1 kb has been identified 
in some erythro!eukemic ce!! lines and in spleen cells of 
anemic adult mice [21,24] but EPO-R mRNA of fetal 
liver cells has not been analyzed. First, we detected 
EPO-R mRNA of fetal mouse liver cells by Northern 
blotting and compared it with mRNAs in adult mouse 
cells and cell lines (Fig. 2). A single band at the position 
of 2.1 kb was found with poly(A)-selected RNA from 
fetal mouse liver cells on day 13 of gestation (lane 1 in 
Fig. 2). The size was consistent with that found with 
TSA8 (a mouse erythroleukemic cell liiie) (lane 2), and 
spleen cells of an adult mouse made anemic by phenyl- 
hydrazine treatment (lane 3), and ELM (a transplant- 
able mouse erythroleukemic cell line) (lane 4). These 
cells have been shown to express EPO-R on their cell 
surfaces by assays of EPO binding [6-S]. EPO-R 
mRNA was undetectable inadult mouse liver cells, M 1 
(a mouse myelomonocytic cell line), and mouse reticu- 
locytes (lanes 5-7); these cells did not express EPO-R on 
their cell surfaces [6]. Second, to examine the devel- 
opmental changes in the amount of EPO-R mRNA, 
slot-blot analysis was done with total RNA prepared 
from fetal mouse livers on days 13, 16, and 19 of gesta- 
tion (Fig. 3a). The intensity of bands on each day of 
gestation, measured with a densitometer, was propor- 
tional to the amount of RNA used (data not shown}. 
The amount of EPO-R mRNA decreased as the gesta- 
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tion advanced (Fig. 3a), but that of actin mRNA 
remained constant (Fig. 3b). I?easitometric measure- 
ments of the intensity of the bands clearly show the 
gestation age-dependent decrease in EPO-R mRNA 
(Fig. 3~). Thus, the number of EPO-R per fetal liver cell 
could be directly related to the amount of EPO-R 
mRNA. These results indicate that the binding affinity 
of EPO-R on erythroid precursor cells did not change 
during the development of the mouse fetus and that the 
significant contribution of translational and/or post- 
translational regulation to EPO-R expression on the cell 
surface is unlikely. 
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